↓ Skip to main content

Targeting PI3K in cancer: mechanisms and advances in clinical trials

Overview of attention for article published in Molecular Cancer, February 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
2 news outlets
blogs
2 blogs
twitter
1 X user
patent
2 patents
f1000
1 research highlight platform

Citations

dimensions_citation
1001 Dimensions

Readers on

mendeley
1007 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Published in
Molecular Cancer, February 2019
DOI 10.1186/s12943-019-0954-x
Pubmed ID
Authors

Jing Yang, Ji Nie, Xuelei Ma, Yuquan Wei, Yong Peng, Xiawei Wei

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1,007 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1007 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 137 14%
Student > Bachelor 114 11%
Student > Master 96 10%
Researcher 90 9%
Student > Doctoral Student 41 4%
Other 119 12%
Unknown 410 41%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 239 24%
Medicine and Dentistry 79 8%
Agricultural and Biological Sciences 59 6%
Pharmacology, Toxicology and Pharmaceutical Science 50 5%
Chemistry 28 3%
Other 101 10%
Unknown 451 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 36. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2024.
All research outputs
#1,154,234
of 26,017,215 outputs
Outputs from Molecular Cancer
#57
of 1,962 outputs
Outputs of similar age
#26,757
of 370,553 outputs
Outputs of similar age from Molecular Cancer
#2
of 54 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,962 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 370,553 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.